Showing Results : 1-1 of 1
Sort By :
Oncology and Therapy

Published By Adis, Springer Healthcare

  • Oncology and Therapy: 2023, vol: 11, issue: 1
  • 1)- Ohad Ronen, K Thomas Robbins, Ashok R Shaha, Luiz P Kowalski, Antti A Mäkitie, Ewa Florek, Alfio Ferlito. Emerging Concepts Impacting Head and Neck Cancer Surgery Morbidity. Oncology and therapy. 2023, 11 (1): 1-13
    Cited : 1
    Read More
  • 2)- Sandrine Barbier, Benjamin Beaufils, Ricardo de Miguel, Melissa Reyre, Yannick Le Meitour, Andreanne Lortie, Marc Hillairet de Boisferon, Sophie Chaumeron, Anne Espirito, Lina Fossati, Pauline Lagarde, Stephan Klinz, Arunthathi Thiagalingam, Stéphane Lezmi, Florence Meyer-Losic. Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer. Oncology and therapy. 2023, 11 (1): 111-128
    Cited : 3
    Read More
  • 3)- Louise Barrett, Emma Elliott, Maarten Voorhaar, Anders Ingelgård, Ingolf Griebsch, Brendon Wong, Jessica Mills, Phoebe Heinrich, Stefan Cano. A Mixed-Methods Study to Better Measure Patient-Reported Pain and Fatigue in Soft Tissue Sarcoma. Oncology and therapy. 2023, 11 (1): 129-143
    Cited : 2
    Read More
  • 4)- Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari. Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy. 2023, 11 (1): 15-24
    Cited : 3
    Read More
  • 5)- Dany Habr, Brittany Wolf Gianares, Kristine W Schuler, Dheepa Chari. Correction: Patients at the Heart of the Scientific Dialogue: An Industry Perspective. Oncology and therapy. 2023, 11 (1): 25
    Cited : 0
    Read More
  • 6)- Eleanor Allison, Senarath Edirimanne, Jim Matthews, Stephen J Fuller. Breast Cancer Survival Outcomes and Tumor-Associated Macrophage Markers: A Systematic Review and Meta-Analysis. Oncology and therapy. 2023, 11 (1): 27-48
    Cited : 13
    Read More
  • 7)- Saachi Chhaya, Isabella Watts, Kenrick Ng, Rami Mustapha, Thomas Powles, Anand Sharma, Nikhil Vasdev. Role of Perioperative Immune Checkpoint Inhibitors in Muscle Invasive Bladder Cancer. Oncology and therapy. 2023, 11 (1): 49-64
    Cited : 3
    Read More
  • 8)- Peter Borchmann, Jan-Michel Heger, Jörg Mahlich, Michael S Papadimitrious, Sybille Riou, Barbara Werner. Healthcare Resource Utilization and Associated Costs of German Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Health Claims Data Analysis. Oncology and therapy. 2023, 11 (1): 65-81
    Cited : 2
    Read More
  • 9)- Adrián Alegre, Gonzalo Benzo, Rafael Alonso, Joaquín Martínez-López, Ana Jimenez-Ubieto, Clara Cuéllar, Elham Askari, Elena Prieto, Concepción Aláez, Beatriz Aguado, Alberto Velasco, Isabel Krsnik, Ana Bocanegra, Laura Llorente, Cristina Muñoz-Linares, Ana Morales, Eugenio Giménez, Rebeca Iglesias, Carmen Martínez-Chamorro, Aránzazu Alonso, Carmen Jiménez-Montes, María J Blanchard, . Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP). Oncology and therapy. 2023, 11 (1): 83-96
    Cited : 7
    Read More
  • 10)- Cecilie Ejerskov, Stense Farholt, Flemming Secher Kromann Nielsen, Ingunn Berg, Stine Bogetofte Thomasen, Aparna Udupi, Trude Ågesen, Sofie de Fine Licht, Mette Møller Handrup. Clinical Characteristics and Management of Children and Adults with Neurofibromatosis Type 1 and Plexiform Neurofibromas in Denmark: A Nationwide Study. Oncology and therapy. 2023, 11 (1): 97-110
    Cited : 3
    Read More
 
 


Journal List
Links
Content Links
About Us

0